At present, there is no cure for Best's disease, and about 1000 patients in Taiwan Province suffer from it. Domestic studies have found that induced pluripotent stem cells (iPSC) can improve the ophthalmic drug delivery system, and it is preliminarily found that nano curcumin injection can rejuvenate the retina. There are about 1000 patients with Best's disease in China. Qiu Shihua, director of the Medical Research Department and Ophthalmology Research Department of Taipei Veterans General Hospital, pointed out that macular degeneration can be divided into age-related macular degeneration and hereditary macular degeneration, among which hereditary macular degeneration is called "Best's disease", with an incidence rate of 1 10,000, and only 1 10,000 well-known patients in Taiwan. At present, there is no medicine to treat them. Director Qiu Shihua, who successfully differentiated retinal cells by using iPSC technology, said that the research team used animal experiments to obtain embryonic stem cells from rat deciduous teeth cells and implanted them into the damaged retina, and found that retinal nerves grew again. Using the technology of "induced pluripotent stem cells (iPSC)", it can be successfully differentiated into retinal nerve cells or retinal pigment epithelial cells, which is developing towards precision medicine. Director Qiu Shihua explained that in addition, iPSC technology can be applied to drug screening for patients with hereditary macular disease. For patients with hereditary retinal diseases, curcumin is found to have antioxidant cytoprotective effect on retinal pigment epithelial cells, which can be applied to the development of precision medicine such as developing new drugs and testing small molecular nano-drugs. Subscribe to the health Aloha audio-visual channel, read health knowledge more easily, and pay attention to your health every day! Line @ ID: @:/beauty/article/32761Keywords: hereditary macular disease, Best's disease, curcumin, Qiu Shihua, ophthalmology, Bayonne.